Squarepoint Ops LLC Summit Therapeutics Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.39 - $10.92 $135,307 - $618,224	56,614 Added 192.24%	86,064 $671,000
Q1 2024 May 15, 2024	BUY	$2.55 - $5.07 $75,097 - $149,311	29,450 New	29,450 $121,000
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $394,097 - $1.54 Million	285,578 New	285,578 $499,000
Q1 2021 May 17, 2021	SELL	$5.17 - $11.19 $65,922 - $142,683	-12,751 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.25 - $6.0 $41,440 - $76,506	12,751 New	12,751 $60,000

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.6B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.